Sividon Diagnostics GmbH
Industry / private company
Location:
Köln,
Germany (DE)
ISNI: -
ROR: https://ror.org/033sa9s17
Show on Map:
Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor (2018)
Loibl S, Weber K, Huober J, Krappmann K, Marme F, Schem C, Engels K, et al.
Journal article
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients (2015)
Blank PR, Filipits M, Dubsky P, Gutzwiller F, Lux MP, Brase JC, Weber KE, et al.
Journal article